pharma · IC - Interstitial Cystitis · Interstitial Cystitis · LIPO
LIPELLA PHARMACEUTICALS
LIPELLA PHARMACEUTICALS INC.
Lipella Pharmaceuticals is a pharma organization headquartered in Pittsburgh, USA. It trades on NYSE under ticker LIPO. Primary therapeutic focus areas include IC - Interstitial Cystitis, Interstitial Cystitis, Hemorrhag
Pittsburgh, USA HQ
2005 Founded
3 Employees
Public company Type
LIPO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Pittsburgh, USA
- Founded
- 2005
- Employees
- 3
- Programs
- 4
- Drugs
- 3
- Patents
- 4
LP-10 (Liposomal Tacrolimus)
Phase 2 · small molecule · Oral Lichen Planus
LP-10 (Liposomal Tacrolimus) for Oral Lichen Planus is a Phase 2 program (small_molecule) at LIPELLA PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Internal code 310-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- LIPELLA PHARMACEUTICALS INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Oral Lichen Planus
- Status
- active
- Trials
- 1